Plain-English translation of NCT07559474 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Phase 1 โ Testing in a small group (usually 20โ80 people) to find a safe dose and watch for side effects.
This study is testing a medication called to see how safe it is and how your body handles it when you have moderate or severe liver disease. Because the liver plays a key role in how your body processes medications, researchers need to understand how this treatment works specifically in people with liver problems. This is an early-stage study to gather important safety information.
When the liver doesn't work properly, medications can build up in your body or work differently than expected. This trial exists to make sure this medication is safe for people with liver disease and to understand the right way to use it in this population.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You will join one of two groups based on how severely your liver disease affects you. You'll take the medication by mouth during the study and have regular visits where researchers will check your safety through blood tests, physical exams, and heart monitoring (ECGs). The study involves careful observation to make sure the medication is working safely in your body and to understand how your liver disease affects how you process the treatment.
AI-generated summary from trial data ยท Jun 30, 2026 ยท Not medical advice
United States